13th Annual Neonatal Pharmacology

As we offer our vulnerable patients the best, most contemporary care possible, we need to keep in mind that many pharmacologic therapies have not been thoroughly examined in newborns and risk-benefit ratios are not well established. Although new and complex therapeutic interventions bring potential benefits, they can also create new, often unanticipated, complications.

When influenza outbreaks occur, what new treatments should we consider to protect the susceptible newborn? Treatment of the PDA, low blood pressure and encephalopathy may occur without careful consideration of what data have been developed through peer reviewed studies.

Antibiotics play a major role in the reduction of disease, but resistance is increasing and new drugs often lack thorough testing in the NICU populations who remain at risk for known as well as unanticipated toxicities. A better understanding of pharmacologic therapies can help us avoid undesirable consequences and improve drug therapy in the neonatal population. In response to these challenges, Contemporary Forums presents the 13th Annual Neonatal Pharmacology conference designed for NICU professionals including physicians, nurse practitioners, clinical pharmacists, nurse managers and experienced staff nurses. This conference offers cutting edge information from some of the leading clinicians and researchers in neonatology. You will learn from these experts how to integrate best practices into your unit for a broad range of neonatal drugs, as well as managing care in the light of drug shortages.

If you are struggling to keep up with the recommended medication management for the NICU infant, if you are not sure whether medication delivery in your unit is as safe as it could be, don’t miss this opportunity to update your clinical knowledge of neonatal pharmacology. We look forward to seeing you in La Jolla!